Voxelotor and Abemaciclib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Voxelotor
Abemaciclib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Voxelotor (Oxbryta) can slow down a liver enzyme called CYP3A4. Your body uses that same enzyme to break down abemaciclib (Verzenio). When the enzyme is slowed, abemaciclib can build up higher in your blood than expected.
Higher levels can mean more side effects, like diarrhea, tiredness, or a drop in your blood cell counts. The good news is this is very manageable. Your care team can adjust your abemaciclib dose and keep a closer eye on you with regular checkups and lab work. Please don't stop or change either medicine on your own, just talk with your doctor or pharmacist about this combination.
Mechanism: Voxelotor inhibits CYP3A4, reducing metabolism of CYP3A4 substrates. Abemaciclib is a CYP3A4 substrate, so coadministration is expected to increase abemaciclib exposure (AUC/Cmax), raising the risk of dose-related toxicity (diarrhea, neutropenia, hepatotoxicity, fatigue).
- Direction: increased abemaciclib effect/exposure
- Evidence: theoretical; extrapolated from voxelotor increasing midazolam exposure
- Onset: unspecified
- Severity on file: major
Management: Avoid coadministration where possible. If unavoidable, consider abemaciclib dose reduction and monitor more closely for toxicity (CBC, LFTs, GI symptoms). Individualize per oncology guidance.
What happens
Increased exposure of sensitive CYP3A4 substrates
Interaction Deep Dive
When voxelotor is combined with sensitive CYP3A4 substrates that have a narrow therapeutic index, such coadministration should be avoided. In situations where using them together cannot be prevented, reducing the dose of the sensitive CYP3A4 substrate should be considered. Systemic exposure to midazolam, which is a sensitive CYP3A4 substrate, was raised by voxelotor1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism by voxelotor
How to manage this interaction
What your care team may do:
- Prefer to avoid using these two together when there is an alternative.
- If both are needed, they may reduce your abemaciclib dose, adjusted and individualized to you.
- Monitor you more closely, including blood counts, liver labs, and side effects like diarrhea.
What you can do:
- Keep taking both exactly as prescribed unless your team tells you otherwise.
- Report new or worsening diarrhea, fatigue, fever, or signs of infection promptly.
- Ask your pharmacist or oncologist before starting, stopping, or changing either drug.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) Voxelotor inhibits CYP3A4 in vivo. In healthy subjects, midazolam (a CYP3A4 substrate) showed an observed exposure increase of 1.6-fold, while the predicted increase in patients following multiple dosing is 2.5-fold 1.
Common questions
Can I take Voxelotor and Abemaciclib together?
Voxelotor can raise abemaciclib levels and side effects by slowing its breakdown, so this combination is best avoided; if both are needed, your team may lower the abemaciclib dose and monitor you more closely. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Voxelotor and Abemaciclib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Voxelotor and Abemaciclib interaction managed?
What your care team may do: Prefer to avoid using these two together when there is an alternative. If both are needed, they may reduce your abemaciclib dose, adjusted and individualized to you. Monitor you more closely, including blood counts, liver labs, and side effects like diarrhea. What you can do: Keep taking both exactly as prescribed unless your team tells you otherwise. Report new or wors… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Voxelotor or Abemaciclib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: OXBRYTA(R) oral tablets, tablets for oral suspension, voxelotor oral tablets, tablets for oral suspension. Global Blood Therapeutics Inc (per FDA), San Francisco, CA, 2023. DailyMed
Keep reading about Voxelotor
Keep reading about Abemaciclib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist